Ginkgo Bioworks DNA Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's share-based payment award options outstanding - number?
- Ginkgo Bioworks (DNA) reported share-based payment award options outstanding - number of 366.6K in Q1 2026.
- How has Ginkgo Bioworks's share-based payment award options outstanding - number changed year-over-year?
- Ginkgo Bioworks's share-based payment award options outstanding - number increased by 40.3% year-over-year, from 261.3K to 366.6K.
- What is the long-term trend for Ginkgo Bioworks's share-based payment award options outstanding - number?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's share-based payment award options outstanding - number has grown at a -59.4% compound annual growth rate (CAGR), from 33.4M to 366.6K.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.